Aclarion, Inc.
$3.10
The Read: ACON's stock surged about 129% after Q2 2026 on narrower losses and strong commercialization gains including a second Weill Cornell deal and triple-digit Nociscan growth, but earlier Q1 2026 earnings with revenue misses and cash concerns led to muted or slight declines despite analyst upgrades.
Price
Overlays
Panel
ACON
Hover to view data
No Data